Genome wide association studies (GWAS) have been extremely powerful and successful identifying associations between genetic polymorphisms (SNP) and diabetic and chronic kidney disease (CKD) development. Our next big challenge is to translate this information to understand the mechanism of diabetic and CKD development. The major hurdle is that the majority of CKD associated polymorphisms lie outside the coding region of the genome. Therefore classic protein biochemistry and gene deletion studies of model organisms cannot yet be applied. Several recent pioneering studies have provided a novel framework for such experiments and indicate that the cell type specific epigenome can be used to understand and annotate the non-coding region of the genome. As there are hundreds of established SNPs for CKD, performing individual experiments for each SNP could be a daunting task, therefore there is a critical need for genome wide cell type specific mapping of non-coding regulatory regions and defining the correlation between SNP's and transcript levels. The proposal will use a combination of methods to dissect the association between diabetic and chronic kidney disease associated polymorphisms and disease.
One in ten American -about 20 million people- suffer from chronic kidney disease (CKD). More than half a million people carry the diagnosis of the most severe form of CKD, end stage renal disease (ESRD). ESRD can only be treated with dialysis or transplantation. The yearly mortality rate of patients on dialysis can be as high as 20%, which is higher than patients with prostate or breast cancer. Multiple different approaches have been attempted to understand the mechanism of CKD.
|Beckerman, Pazit; Ko, Yi-An; Susztak, Katalin (2014) Epigenetics: a new way to look at kidney diseases. Nephrol Dial Transplant 29:1821-7|
|Hu, Caroline Y; Mohtat, Davoud; Yu, Yiting et al. (2014) Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival. Clin Cancer Res 20:4349-60|
|Susztak, Katalin (2014) Understanding the epigenetic syntax for the genetic alphabet in the kidney. J Am Soc Nephrol 25:10-7|
|Wing, Maria R; Devaney, Joseph M; Joffe, Marshall M et al. (2014) DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC study. Nephrol Dial Transplant 29:864-72|
|Ko, Yi-An; Susztak, Katalin (2013) Epigenomics: the science of no-longer-junk DNA. Why study it in chronic kidney disease? Semin Nephrol 33:354-62|
|Woroniecki, Robert; Gaikwad, Anil Bhanudas; Susztak, Katalin (2011) Fetal environment, epigenetics, and pediatric renal disease. Pediatr Nephrol 26:705-11|
|Woroniecka, Karolina I; Park, Ae Seo Deok; Mohtat, Davoud et al. (2011) Transcriptome analysis of human diabetic kidney disease. Diabetes 60:2354-69|
|Chang, Gene-Yuan; Park, Ae Seo Deok; Susztak, Katalin (2011) Tracing the footsteps of glomerular insulin signaling in diabetic kidney disease. Kidney Int 79:802-4|
|Mohtat, Davoud; Susztak, Katalin (2010) Fine tuning gene expression: the epigenome. Semin Nephrol 30:468-76|
|Reidy, Kimberly; Susztak, Katalin (2009) Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease. Am J Kidney Dis 54:590-3|